Comparison of reproductive outcomes after progestin-primed ovarian stimulation with dydrogesterone versus cetrorelix to inhibit spontaneous ovulation in oocyte donation

被引:0
|
作者
Moreno, J. A. [1 ]
Masoli, P. [2 ]
Sferrazza, C. [2 ]
Leiva, H. [2 ]
Espinosa, O. [2 ]
Hernande Rudnick, P. [2 ]
Lizardo, J. [2 ]
Rivera, F. [2 ]
Plaz de los Reyes, S. [2 ]
Cordova, M. [2 ]
Sferrazza, E. [2 ]
Chavez, N. [2 ]
Sepulveda, M. [2 ]
Jiliberto, B. [2 ]
机构
[1] Univ Autonoma Barcelona, Gynecol & Obstet, Barcelona, Spain
[2] Clin Mujer, Med Reprod, Vina Del Mar, Chile
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P-708
引用
收藏
页码:458 / 459
页数:2
相关论文
共 50 条
  • [1] Progestin primed ovarian stimulation using dydrogesterone in oocyte donation cycles: a longitudinal study
    Hendrickx, S.
    Drakopoulos, P.
    De Munck, N.
    Ruttens, S.
    Tournaye, H.
    De Vos, M.
    Blockeel, C.
    HUMAN REPRODUCTION, 2022, 37 : I505 - I505
  • [2] Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response
    Zhang, Junwei
    Du, Mingze
    Li, Zhen
    Liu, Wenxia
    Ren, Bingnan
    Zhang, Yuchao
    Guan, Yichun
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [3] New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology
    Nanako Iwami
    Miho Kawamata
    Naoko Ozawa
    Takahiro Yamamoto
    Eri Watanabe
    Osamu Moriwaka
    Hirobumi Kamiya
    Archives of Gynecology and Obstetrics, 2018, 298 : 663 - 671
  • [4] New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology
    Iwami, Nanako
    Kawamata, Miho
    Ozawa, Naoko
    Yamamoto, Takahiro
    Watanabe, Eri
    Moriwaka, Osamu
    Kamiya, Hirobumi
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 298 (03) : 663 - 671
  • [5] Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols
    Emmanuelle Mathieu d’Argent
    Clément Ferrier
    Chrysoula Zacharopoulou
    Naouel Ahdad-Yata
    Anne-Sophie Boudy
    Adèle Cantalloube
    Rachel Levy
    Jean-Marie Antoine
    Emile Daraï
    Sofiane Bendifallah
    Journal of Ovarian Research, 13
  • [6] Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols
    d'Argent, Emmanuelle Mathieu
    Ferrier, Clement
    Zacharopoulou, Chrysoula
    Ahdad-Yata, Naouel
    Boudy, Anne-Sophie
    Cantalloube, Adele
    Levy, Rachel
    Antoine, Jean-Marie
    Darai, Emile
    Bendifallah, Sofiane
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [7] Comparison of follitropin delta versus follitropin alfa in progestin-primed ovarian stimulation in IVF
    Okamoto, E.
    Enatsu, N.
    Yamada, K.
    Yamada, A.
    Hayashi, N.
    Enatsu, Y.
    Katayama, K.
    Tokura, Y.
    Yamada, S.
    Mizusawa, Y.
    Kishi, K.
    Kokeguchi, S.
    Shiotani, M.
    HUMAN REPRODUCTION, 2023, 38
  • [8] New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone
    Iwami, Nanako
    Kawamata, Miho
    Ozawa, Naoko
    Yamamoto, Takahiro
    Watanabe, Eri
    Mizuuchi, Masahito
    Moriwaka, Osamu
    Kamiya, Hirobumi
    REPRODUCTIVE BIOLOGY, 2021, 21 (01)
  • [9] Comparison of an HCG-only trigger versus dual trigger for final oocyte maturation in a progestin-primed ovarian stimulation protocol
    Li, Qian
    Li, Xiaolan
    Li, Tingting
    Xu, Linan
    Wang, Yanfang
    Huang, Rui
    REPRODUCTIVE BIOMEDICINE ONLINE, 2022, 45 (06) : 1176 - 1181
  • [10] Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study
    Huang, Jialyu
    Xie, Qin
    Lin, Jiaying
    Lu, Xuefeng
    Zhu, Jing
    Gao, Hongyuan
    Cai, Renfei
    Kuang, Yanping
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 4461 - 4470